A Pilot Study for Detection of PSMA-Low Castration Resistant and Neuroendocrine Prostate Cancer With 18F-fluciclovine PET/CT Imaging
Latest Information Update: 07 Feb 2025
At a glance
- Drugs Fluciclovine 18F (Primary)
- Indications Neuroendocrine carcinoma; Prostate cancer
- Focus Diagnostic use
- Sponsors Blue Earth Diagnostics
- 25 Jun 2024 Status changed from not yet recruiting to recruiting.
- 09 Oct 2023 New trial record